Clinical Trials Directory

Trials / Unknown

UnknownNCT00989846

Biomarker in Lung Diseases

Feasibility Study on Establishing Biomarkers in Lung Diseases

Status
Unknown
Phase
Study type
Observational
Enrollment
120 (estimated)
Sponsor
Heidelberg University · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

Disease related biomarkers have been established decades ago, e.g. blood glucose for diabetes diagnosis and management. Their discovery has grown dramatically during the past decade and they have the potential to lead the physician in diagnosis -especially differential diagnosis - and therapy. However, a specific serum-biomarker in lung diseases has not been established. Aim of the current study is to to measure lung specific proteins in the serum in patients with various lung diseases and to correlate those with disease severity, lung function and other laboratory results

Conditions

Interventions

TypeNameDescription
OTHERbiomarkermeasuring serum-biomarkers

Timeline

Start date
2009-10-01
Primary completion
2010-03-01
Completion
2010-06-01
First posted
2009-10-06
Last updated
2009-10-14

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT00989846. Inclusion in this directory is not an endorsement.

Biomarker in Lung Diseases (NCT00989846) · Clinical Trials Directory